control group Clinical Trials

3 actively recruiting trials

▼ -1 trial since July 2026

Also known as: Group 3

Pipeline

Phase 4: 1Phase 1/2: 1Phase 2/3: 1

Top Sponsors

The First Hospital of Jilin University1
Ever Supreme Bio Technology Co., Ltd.1
Anhui Provincial Hospital1

Indications

Cancer2
Liver Disease1
Multiple Sclerosis1
Hepatocellular Carcinoma (HCC)1
Rectal Cancer1

Other3 trials

Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

Phase 2/3

Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Phase 1/2

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.